An international expert in expanded access to experimental drugs, Marjorie A. Speers, Ph.D., will speak at the third annual Expanded Access Summit Jan. 27-29 at the National Press Club in Washington, D.C. Speers, a former CDC official, is the executive director of Clinical Research Pathways, a nonprofit that develops programs that increase diversity in clinical research and expand access to experimental pharmaceuticals. By opening access and advancing treatments, Clinical Research Pathways helps make new, effective medicines available to the public. In addition to her talks and panel participation, Speers will be available for press interviews. For more information about Speers, visit the organization website above, or contact Mark Marchand at [email protected] The overall program for the conference is at: